![](/img/cover-not-exists.png)
PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas
Black, J.D., Lopez, S., Cocco, E., Bellone, S., Altwerger, G., Schwab, C.L., English, D.P., Bonazzoli, E., Predolini, F., Ferrari, F., Ratner, E., Silasi, D.A., Azodi, M., Schwartz, P.E., Santin, A.D.Volume:
139
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2015.09.058
Date:
December, 2015
File:
PDF, 44 KB
english, 2015